Major Events - Saimo Technology (02571) plans to introduce strategic investment of 12.0098 million yuan to build a full-chain automotive electronic simulation business capability [1] - Hutchison China MediTech (00013) announced positive top-line results from the Phase III ESLIM-02 study of solitomab for the treatment of warm antibody autoimmune hemolytic anemia in China [1] - China Carbon Neutral (01372) signed a tripartite strategic cooperation agreement with China Tower and China Renewable Resources to jointly create a lithium battery recycling economic ecosystem [1] - Livzon Pharmaceutical (01513) has its Lecanemab injection included in the priority review and approval process [1] - Mao Ge Ping (01318) signed a strategic cooperation framework agreement with Luwei Kaiteng [1] - Tiangong International (00826) plans to transfer its 1.76% stake in Tiangong Tools to Tiangong New Materials for 180 million yuan [1] - Heng Rui Medicine (01276) received drug registration approval for Rilapladib α injection [1] - Zheng Tong Automobile (01728) announced that Qifu Group intends to sell 803 million yuan of equity in Shenzhen Huianqi, focusing on automotive business transformation [1] - Tongyuan Kang Pharmaceutical-B (02410) plans to include Alectinib tablets (TY-9591 tablets) in priority review [1] - Jinglian Group (01751) subsidiary signed an engineering contract for the second phase of the industrial waste gas power generation project in Sunite Right Banner [1] Operating Performance - Jitu Express-W (01519) reported a total parcel volume of 30.1287 billion pieces in 2025, a year-on-year increase of 22.2% [1] - Qin Port Co., Ltd. (03369) projected a total throughput of 433 million tons for 2025, a year-on-year growth of 4.48% [1] - GAC Group (02238) reported December automobile sales of 187,500 units, a year-on-year decline of 33.82% [1] - Greentown China (03900) estimated total contract sales of approximately 251.9 billion yuan in 2025, a year-on-year decrease of 9% [1] - Agile Group (03383) projected total pre-sale amount of 8.57 billion yuan in 2025, a year-on-year decrease of 44.75% [1] - China Overseas Macro Group (00081) achieved contract sales of 2.57 billion yuan in December 2025, a year-on-year decline of 43.9% [1] - Hongyang Real Estate (01996) reported cumulative contract sales of 4.33 billion yuan in 2025, a year-on-year decrease of 50.91% [1] - Xinli International (00732) reported cumulative net operating revenue of approximately 16.534 billion HKD in 2025, a year-on-year decrease of about 7.3% [1]
港股公告掘金 | 极兔速递-W2025年包裹量合计301.287亿件，同比增长22.2%